Evaluations of Biomarker Status Changes between Primary and Recurrent Tumor Tissue Samples in Breast Cancer Patients.
Thi Hoa NguyenVan Hung NguyenLong Thanh NguyenCai QiuyinThi Huyen PhungPublished in: BioMed research international (2019)
A substantial discordance in ER, PR, and HER2 status were observed between primary breast cancer tissues and recurrent lesions. Rebiopsy could bring new therapeutic opportunities in the management of patients with recurrent breast cancer.
Keyphrases